UFP Technologies, Inc. Business Acquisition, Pro Forma Revenue
UFP Technologies, Inc. (UFPT) reported Business Acquisition, Pro Forma Revenue of $148.51 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2025-08-11
- UFP Technologies, Inc. business acquisition, pro forma revenue for the quarter ending 2024-09-30 was $148.51M, a 15.90% increase year-over-year.
- UFP Technologies, Inc. business acquisition, pro forma revenue for the quarter ending 2024-06-30 was $144.19M.
- UFP Technologies, Inc. business acquisition, pro forma revenue for the quarter ending 2024-03-31 was $135.16M.
- UFP Technologies, Inc. business acquisition, pro forma revenue for the quarter ending 2023-09-30 was $128.14M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month |
|---|---|---|---|
| 2024-09-30 | $148.51M 10-Q · filed 2024-11-12 | $292.70M derived: sum of 2 quarters · filed 2025-08-11 | $435.49M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $144.19M 10-Q · filed 2025-08-11 | $279.35M 10-Q · filed 2025-08-11 | |
| 2024-03-31 | $135.16M 10-Q · filed 2025-05-12 | ||
| 2023-09-30 | $128.14M 10-Q · filed 2024-11-12 | $378.11M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |